Phathom Pharmaceuticals I... (PHAT)
NASDAQ: PHAT
· Real-Time Price · USD
10.60
-0.04 (-0.38%)
At close: Jun 16, 2025, 3:59 PM
10.55
-0.47%
After-hours: Jun 16, 2025, 07:59 PM EDT
-0.38% (1D)
| Bid | 10.53 |
| Market Cap | 740.03M |
| Revenue (ttm) | 81.86M |
| Net Income (ttm) | -251.47M |
| EPS (ttm) | -5.18 |
| PE Ratio (ttm) | -2.05 |
| Forward PE | -33.3 |
| Analyst | Buy |
| Ask | 10.69 |
| Volume | 1,669,650 |
| Avg. Volume (20D) | 2,717,104 |
| Open | 10.63 |
| Previous Close | 10.64 |
| Day's Range | 9.93 - 10.68 |
| 52-Week Range | 2.21 - 19.71 |
| Beta | 0.10 |
About PHAT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PHAT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PHAT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+90.19%
Phathom Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
1 month ago
-17.86%
Phathom Pharmaceuticals shares are trading lower after HC Wainwright maintained a Buy rating on the stock and lowered its price target from $28 to $20.
1 week ago · https://thefly.com
Phathom Pharmaceuticals price target raised by $6 at Cantor Fitzgerald, here's why19 Aug
